Biofy in the Spotlight at Oracle's Data & AI Forum: Innovation and AI Highlighted in Brazil

Last Tuesday, August 26, the CEO of Biofy, Paulo Perez, was present at the Oracle Data & AI Forum, held in São Paulo — a strategic event that brings together leaders, specialists, and enthusiasts to discuss the future of artificial intelligence and digital transformation in Latin America. At the meeting, Paulo shared the stage with Oracle's Senior Director of AI Engineering, Alexandre Nakahara, and highlighted the advancements and challenges of AI, as well as presenting the solutions developed by Biofy that are already gaining space in the market.

The Oracle Data & AI Forum is part of a global series dedicated to showcasing the latest advances in data, AI, and cloud infrastructure. In its 2024 edition, held at the Tomie Ohtake Institute, the event highlighted the importance of generative AI and cloud adoption as pillars of digital transformation — with over 100 AI features and 50 agents integrated into Oracle's platforms. Furthermore, leaders like Alexandre Maioral, president of Oracle Brazil, emphasized that “when applied correctly, AI can be a growth and business differentiation engine.” The meeting also discussed the relevance of training talent in AI, such as through the social program ONE, which focuses on employability and technological training.

At the event, Biofy played a prominent role by presenting Abby, a revolutionary technology developed by the Biofy Genomics division. It is an AI-based antibiotic recommender that uses genetic sequencing to identify pathogens and accurately and swiftly indicate the most effective treatment — reducing laboratory tests from up to 5 days to just 4 hours. This advancement demonstrates how the combination of biotechnology and artificial intelligence can concretely transform the healthcare sector, reinforcing Biofy's commitment to impactful and high-value solutions.

During the Data & AI Forum, Paulo Perez highlighted: “We are increasingly committed to developing solutions that combine biotechnology and artificial intelligence to transform the way health is treated in Brazil and worldwide.” This statement reinforces the role of the partnership with Oracle as the foundation for developing tools like Abby, which have the potential to positively impact the healthcare sector.

Brazil, according to Leandro Vieira, vice president of AI and High Tech companies at Oracle in Latin America, has advanced rapidly — now at a moment of technological maturity comparable to that of the US about two years ago. In this context, Biofy's work alongside Oracle exemplifies how Brazilian startups are positioning themselves as references in the adoption of AI and technological innovation.

In summary, Biofy's participation in the Oracle Data & AI Forum reinforces its leadership at the interface between biotechnology and artificial intelligence — with concrete solutions like Abby that elevate health to levels of precision, speed, and social impact. By bringing this content to the blog, we are creating a narrative that combines effective SEO with true relevance in the age of AI.